Frederick B. Stehman

9.3k total citations · 1 hit paper
111 papers, 6.0k citations indexed

About

Frederick B. Stehman is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Epidemiology. According to data from OpenAlex, Frederick B. Stehman has authored 111 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Reproductive Medicine, 47 papers in Obstetrics and Gynecology and 37 papers in Epidemiology. Recurrent topics in Frederick B. Stehman's work include Ovarian cancer diagnosis and treatment (51 papers), Endometrial and Cervical Cancer Treatments (45 papers) and Cervical Cancer and HPV Research (30 papers). Frederick B. Stehman is often cited by papers focused on Ovarian cancer diagnosis and treatment (51 papers), Endometrial and Cervical Cancer Treatments (45 papers) and Cervical Cancer and HPV Research (30 papers). Frederick B. Stehman collaborates with scholars based in United States, Canada and Australia. Frederick B. Stehman's co-authors include Brian N. Bundy, Henry Keys, Deborah J. Gersell, Joan L. Walker, Laila I. Muderspach, Weldon Chafe, Clarence E. Ehrlich, Gregory P. Sutton, Philip J. DiSaia and Wesley C. Fowler and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Frederick B. Stehman

110 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma

1999 1.5k citations Henry Keys, Brian N. Bundy et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Frederick B. Stehman

Since Specialization

Citations

This map shows the geographic impact of Frederick B. Stehman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick B. Stehman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick B. Stehman more than expected).

Fields of papers citing papers by Frederick B. Stehman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick B. Stehman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick B. Stehman. The network helps show where Frederick B. Stehman may publish in the future.

Co-authorship network of co-authors of Frederick B. Stehman

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick B. Stehman. A scholar is included among the top collaborators of Frederick B. Stehman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick B. Stehman. Frederick B. Stehman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience 2017 ·Gynecologic Oncology ·Kate Oliver, William E. Brady, Michael J. Birrer, David M. Gershenson, Gini F. Fleming, Larry J. Copeland, Krishnansu S. Tewari, Peter A. Argenta, Robert S. Mannel, Angeles Alvarez Secord, (unknown), David G. Mutch, Frederick B. Stehman, Franco M. Muggia, Peter G. Rose, Deborah K. Armstrong, Michael A. Bookman, Robert A. Burger, John Farley	62
2	Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis 2016 ·Gynecologic Oncology ·Kathleen N. Moore, James Java, (unknown), Peter G. Rose, Rachelle Lanciano, Paul DiSilvestro, J.T. Thigpen, Yi-Chun Lee, Krishnansu S. Tewari, Junzo Chino, Shelly Seward, David S. Miller, Ritu Salani, David H. Moore, Frederick B. Stehman	31
3	Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy 2015 ·PMC ·Peter G. Rose, James Java, Charles W. Whitney, Frederick B. Stehman, Rachelle Lanciano, Gillian Thomas, Paul DiSilvestro	3
4	Identification of the optimal pathway to reach an accurate diagnosis in the absence of an early detection strategy for ovarian cancer 2012 ·Gynecologic Oncology ·Lisa M. Hess, Frederick B. Stehman, Michael Method, Tess D. Weathers, (unknown), Jeanne M. Schilder	4
5	Cytokine use and survival in the first-line treatment of ovarian cancer: A Gynecologic Oncology Group Study 2012 ·Gynecologic Oncology ·Frederick B. Stehman, Mark F. Brady, J.T. Thigpen, Emma Rossi, Robert A. Burger	6
6	Impact of hydronephrosis on outcome of stage IIIB cervical cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: A Gynecologic Oncology Group study 2010 ·Gynecologic Oncology ·Peter G. Rose, Shamshad Ali, Charles W. Whitney, Rachelle Lanciano, Frederick B. Stehman	36
7	Outcome of Reproductive Age Women with Stage IA or IC Invasive Epithelial Ovarian Cancer Treated with Fertility-Sparing Therapy 2002 ·Gynecologic Oncology ·Jeanne M. Schilder, Amy Thompson, Paul D. DePriest, Frederick R. Ueland, Michael L. Cibull, Richard J. Kryscio, Susan C. Modesitt, Karen H. Lu, John P. Geisler, Robert V. Higgins, Paul M. Magtibay, David E. Cohn, Matthew A. Powell, Christina Chu, Frederick B. Stehman, J. van Nagell	179
8	The Significance of Thrombocytosis in Patients with Locally Advanced Cervical Carcinoma: A Gynecologic Oncology Group Study 2000 ·Gynecologic Oncology ·Enrique Hernández, Kathleen Donohue, Lisa Anderson, Paul B. Heller, Frederick B. Stehman	78
9	Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma breakdown → 1999 ·New England Journal of Medicine ·Henry Keys, Brian N. Bundy, Frederick B. Stehman, Laila I. Muderspach, Weldon Chafe, (unknown), Joan L. Walker, Deborah J. Gersell	1486
10	Concurrent chemotherapy and radiation therapy in primary cancer of the cervix 1999 ·Current Oncology Reports ·Jeanne M. Schilder, Frederick B. Stehman	4
11	Gynecologic cancers metastatic to the breast 1998 ·Journal of the American College of Surgeons ·David H. Moore, (unknown), Jean Hurteau, Katherine Y. Look, Frederick B. Stehman, Gregory P. Sutton	45
12	Evaluation and Comparison of Histopathologic Grading Systems of Epithelial Carcinoma of the Uterine Cervix 1994 ·International Journal of Gynecological Pathology ·Richard J. Stock, R.J. Zaino, B. Bundy, Frederic B. Askin, Joan E. Woodward, Bernard F. Fetter, (unknown), Philip J. DiSaia, Frederick B. Stehman	21
13	Proliferative and Cytotoxic Responses of Human Cord Blood T Lymphocytes Following Allogeneic Stimulation 1994 ·Cellular Immunology ·G Risdon, Jennifer A. Gaddy, Frederick B. Stehman, Hal E. Broxmeyer	138
14	Groin dissection versus groin radiation in carcinoma of the vulva: A gynecologic oncology group study 1992 ·International Journal of Radiation OncologyBiologyPhysics ·Frederick B. Stehman, Brian N. Bundy, Gillian Thomas, Mahesh A. Varia, Takashi Okagaki, James A. Roberts, Jeffrey A. Bell, Paul B. Heller	134
15	Recurrent squamous carcinoma of the vulva 1992 ·American Journal of Obstetrics and Gynecology ·(unknown), Gregory P. Sutton, Katherine Y. Look, Frederick B. Stehman, Clarence E. Ehrlich, Ned B. Hornback	32
16	Experience with hydroxyurea as a radiosensitizer in carcinoma of the cervix. 1992 ·PubMed ·Frederick B. Stehman	6
17	DNA content as a prognostic index in gestational trophoblastic neoplasia 1989 ·Gynecologic Oncology ·Roland Martinꝉ, Gregory P. Sutton, Thomas M. Ulbright, George W. Sledge, Frederick B. Stehman, Clarence E. Ehrlich	12
18	A phase II evaluation of mitolactol in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. 1989 ·Journal of Clinical Oncology ·Frederick B. Stehman, J A Blessing, Ramon McGehee, R J Barrett	31
19	Features associated with survival and disease-free survival in early endometrial cancer 1989 ·American Journal of Obstetrics and Gynecology ·Gregory P. Sutton, Hans E. Geisler, Frederick B. Stehman, Peter Young, (unknown), Clarence E. Ehrlich	29
20	A Phase II study of carboplatin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group study) 1986 ·Investigational New Drugs ·James C. Arseneau, John A. Blessing, Frederick B. Stehman, Ramon McGehee	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact